Clinical Trials Directory

Trials / Completed

CompletedNCT03482232

Consequences of Doing What Should Not be Done in Primary Care

Status
Completed
Phase
Study type
Observational
Enrollment
750,000 (actual)
Sponsor
Universidad Miguel Hernandez de Elche · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Retrospective observational study in a random selection of 5% of digital records active between 2014 and 2017 to quantify the frequency of Do not do primary care recommendations, calculating the over-cost related to them and study reviewing a random selection of cases previously identified to determine whether patient suffered adverse events and their over-cost.

Detailed description

Basement: Overuse subjected patients to unnecessary risk without promoting a sufficient clinical benefit and over-cost. The Less is More Medicine movement has led to the identification of Do not do in different specialties, also in primary care. Objective: To analyze the impact of errors (overuse rates based in Do not do recommendations) in clinical practice. Method: Retrospective observational study in a random selection of 5% of digital records active between 2014 and 2017 to quantify the frequency of Do not do primary care recommendations, calculating the over-cost related to them. Retrospective study reviewing a random selection of cases previously identified to determine whether patient suffered adverse events and their over-cost. Setting. Primary care in Andalucía, Aragón, Castilla La Mancha, Comunidad Valenciana, Madrid, Murcia, Navarra y País Vasco, eight autonomous communities in Spain.

Conditions

Interventions

TypeNameDescription
DRUGBenzodiazepinesBenzodiazepines for insomnia, agitation or delirium in people older than 65
DRUGNon-steroidal anti-inflammatory drugsNon-steroidal anti-inflammatory drugs in patients with cardiovascular disease, chronic kidney disease, hypertension, heart failure or liver cirrhosis
DRUGparacetamolparacetamol 1g for more than 3 days
DRUGAntimicrobial agentantibiotic in acute bronchitis when the patient does not suffer from COPD, heart failure, diabetes or kidney disease or is undergoing active chemotherapy
DRUGLipid-lowering drugLipid-lowering drugs in patients older than 75 years without previous cardiovascular events
DIAGNOSTIC_TESTProstate cancerScreening for prostate cancer in asymptomatic patients
RADIATIONLumbagoimage tests in non-specific lumbago
DRUGAntimicrobial agentantibiotics for pharyngitis (infants)
DRUGMucolyticmucolytics, antitussives or antibiotics for upper respiratory infections (infants)
DRUGIbuprofen and paracetamoltreatment with ibuprofen and paracetamol (infants)

Timeline

Start date
2018-10-14
Primary completion
2019-12-05
Completion
2020-02-10
First posted
2018-03-29
Last updated
2020-04-03

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT03482232. Inclusion in this directory is not an endorsement.

Consequences of Doing What Should Not be Done in Primary Care (NCT03482232) · Clinical Trials Directory